Skip to content
Use caution Drug recall · FDA · Published April 18, 2025

FDC Limited Timolol Ophthalmic Solution 10mL Recall: Cap Stuck in Nozzle

FDC Limited recalls 10mL Timolol Maleate Ophthalmic Solution bottles due to cap stuck in nozzle. Rx only product with lot #083I098 expires 08/31/2025. Stop using if unable to dispense solution.

🇺🇸 FDA recall #D-0403-2025DrugFDC Limited ›
Take action

Contact the company

Recalling firmFDC LimitedB-8 MIDC Industrial Area, Waluj District · Aurangabad, Maharashtra State, India
✎ GovInfoNow plain-language explainer

FDC Limited is recalling 10mL Timolol Maleate Ophthalmic Solution bottles because the cap spike gets stuck in the nozzle, making it impossible to get the solution out. This affects people who need prescription eye drops and could lead to improper medication use. Read more at govinfonow.com/recall/32128-fdc-limited-timolol-ophthalmic-solution-10ml-recall-cap-stuck-in.

Source Summary by GovInfoNow · govinfonow.com/recall/32128-fdc-limited-timolol-ophthalmic-solution-10ml-recall-cap-stuck-in · Updated August 17, 2026 · FDA enforcement record: FDA #D-0403-2025

Cite this page

“FDC Limited Timolol Ophthalmic Solution 10mL Recall: Cap Stuck in Nozzle.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32128-fdc-limited-timolol-ophthalmic-solution-10ml-recall-cap-stuck-in. Based on FDA recall #D-0403-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0403-2025%22&limit=1).

The FDA announced on April 18, 2025, that FDC Limited is recalling Timolol Maleate Ophthalmic Solution USP due to a defective container. The hazard prevents users from getting the solution out of the bottle. Owners should contact Rising Pharmaceuticals Inc for a remedy.

How to tell if you have it

  • Brand: FDC Limited
  • Product: Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 10mL bottles
  • NDC: 64980-514-01
  • Lot #: 083I098
  • Exp. Date: 08/31/2025
  • Units affected: 60,428 bottles

The hazard

The spike of the cap is lodged in the nozzle of the product bottle, making it impossible to get the solution out. This defect classifies the recall as Class II.

Context

GovInfoNow's records show FDC Limited has 10 other recalls on record since April 25, 2024. Other recent recalls of similar products include Micro Labs Dorzolamide/Timolol Eye Drops Recall (July 22, 2026), Apotex Desmopressin Nasal Spray Recall (April 8, 2026), and Fagron Recalls Tropicamide Eye Drops Due to Incorrect Formulation (Nov. 20, 2025).

How to tell if you have this one

Check for Timolol Maleate Ophthalmic Solution 10mL bottles with lot number 083I098, manufactured by FDC Limited in Waluj, India, and distributed by Rising Pharmaceuticals Inc. The product expires on 08/31/2025.

  • Brand
    FDC Limited
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Cap Function

    Ensure you can dispense the solution by pressing the cap; if stuck, stop using the bottle immediately.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

1. Firm started the recall: Apr 18, 202512. FDA classified it Class II: May 5, 202523. Published in FDA’s Enforcement Report: May 14, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0403-2025 (April 18, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0403-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA